Document Detail

Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers.
MedLine Citation:
PMID:  8819027     Owner:  NLM     Status:  MEDLINE    
This study is a prospective multicenter cooperative survey of the evaluation and treatment of erectile dysfunction in men with spinal cord injury (SCI). Uniform database questionnaires were completed prospectively by patients seeking therapy for erectile dysfunction. Eighty-five SCI men aged 17-68 years (mean age = 26 +/- 17) were enrolled. Mean duration of traumatic SCI was 3 +/- 3.2 years (Range = 0.3-18 years). The level of injury was cervical in 20 patients, thoracic in 31, lumbar in 29 and sacral in five. Patients were fully evaluated and then counseled as to their therapeutic options. Twenty-eight chose to use a vacuum erection device (VED), 26 preferred pharmacological penile injection and five used both intracorporeal therapy and VED. The remainder were managed with marriage and sexual counseling in 10 patients, three underwent penile prosthesis placement and two used topical pharmacotherapy. Four patients used other forms of treatment and in nine no therapy was recommended. Of the patients that used pharmacologic injection only, 74 percent used papaverine as a single agent, 20 percent used papaverine with phentolamine, five percent used prostaglandin E (PGE1) alone and one percent used a mixture. Patients using injection therapy report sexual intercourse a mean of 3 +/- 3.4 times per month as compared with 5 +/- 3.2 times per month in those using VED. Five intracorporeal injection patients developed priapism while two patients using the VED developed subcutaneous bleeding and one developed penile ischemia. We conclude that although a spectrum of erectile dysfunction treatment is present among SCI centers, VED and pharmacological penile injection are by far the two most popular methods of treatment and papaverine is the most common drug. The incidence of complications is small in the model centers.
T Watanabe; M B Chancellor; D A Rivas; I H Hirsch; C J Bennett; M V Finocchiaro; S Razi; J K Bennett; B G Green; J E Foote; R W Killorian; S Juma; T A Linsenmeyer; K Lloyd
Related Documents :
20110117 - Intravesical injections of botulinum toxin type a for management of neuropathic bladder...
8915047 - Ultrasound-guided injection of ganglia with coricosteroids.
20464617 - Greater occipital nerve block in chronic migraine.
25395657 - Percutaneous injection of radiopaque gelified ethanol for the treatment of lumbar and c...
14585367 - Strategies to reduce transplant-related mortality after allogeneic stem cell transplant...
17980277 - Early and mid-term results of ruptured abdominal aortic aneurysms in the endovascular e...
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  The journal of spinal cord medicine     Volume:  19     ISSN:  1079-0268     ISO Abbreviation:  J Spinal Cord Med     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1996-12-27     Completed Date:  1996-12-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9504452     Medline TA:  J Spinal Cord Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  186-9     Citation Subset:  IM    
Thomas Jefferson University, Philadelphia, PA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alprostadil / administration & dosage
Impotence, Vasculogenic / epidemiology,  rehabilitation*
Middle Aged
Papaverine / administration & dosage
Patient Satisfaction
Penile Prosthesis
Phentolamine / administration & dosage
Prospective Studies
Rehabilitation Centers
Spinal Cord Injuries / epidemiology,  rehabilitation*
United States
Reg. No./Substance:
50-60-2/Phentolamine; 58-74-2/Papaverine; 745-65-3/Alprostadil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Testicular blood flow following spinal cord injury in the Sprague Dawley rat.
Next Document:  Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia.